NikunjShahMD
Gastroenterology • Chicago, ILHepatology & Liver Transplantation
Associate Professor, Section of Hepatology, Rush Medical College of Rush University
Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
840 S Wood St
University of Illinois Medical Center
Chicago, IL 60612Phone+1 312-413-9037Fax+1 312-996-1334
Education & Training
University of ChicagoFellowship, Gastroenterology, 1980 - 1982
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1977 - 1980
Mercy Hospital and Medical CenterInternship, Transitional Year, 1973 - 1974
N.H.L Municipal Medical CollegeClass of 1973
Certifications & Licensure
IL State Medical License 1975 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01
- Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy Start of enrollment: 2013 Apr 03
Publications & Presentations
PubMed
- Breakthrough Hepatitis B Virus Infection in a Liver Transplant Recipient on Lamivudine Prophylaxis for Donor Hepatitis B Core Antibody Seropositivity: A Review of Prac...Eric Bhaimia, Jae Hyung Jung, Edie L. Chan, Nikunj Shah, Carlos A. Q. Santos
Clinical Liver Disease. 2021-07-01 - 87 citationsExtracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial.Julie A. Thompson, Natasha Jones, Ali Al-Khafaji, Shahid M. Malik, David J. Reich
Liver Transplantation. 2018-03-01 - 7 citationsLimited Hepatitis B Immunoglobulin With Potent Nucleos(t)ide Analogue Is a Cost-Effective Prophylaxis Against Hepatitis B Virus After Liver TransplantationG.A. Singer, Shannon Zielsdorf, Vidya A Fleetwood, N. Alvey, E. Cohen
Transplantation Proceedings. 2015-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
